The CDG asks for your consent: We would like to process your pseudonymised data about the use of the website for analysis purposes in order to understand how visitors use our website so that we can make it even better and more intuitive. We use the open-source software Matomo for this purpose. By clicking on "accept all" you can give us your consent for this. You can revoke your consent at any time with effect for the future. You can withdraw your consent at any time by clicking the button "Customise cookie settings" and unchecking the "Analyse" box. The legality of the processing carried out up to that point is not affected by the cancellation.
Without your consent, we will only process your data to the extent technically necessary to display the website to you. Information on the required data processing and the technically required cookies can be found after clicking on the "Settings" button under "Required cookies" and in our privacy policy.
CD Laboratory for Activation of Immunogenic Cell Death in Lung Cancer
Head of research unit
Commercial Partner
Boehringer Ingelheim RCV GmbH & Co KG
Duration
01.01.2026 - 31.12.2032
Thematic Cluster
Medicine
Cancer cells can be eliminated by the body‘s own immune system, supported by so-called immunotherapies or chemo-immunotherapies, and in many patients, tumours can be controlled in the long term. However, non-small cell lung cancer (NSCLC) remains extremely difficult to treat because it is highly effective at evading this immune defence. This often leads to relapses within months or a few years.
The CD laboratory for “Activation of immunogenic cell death lung cancer” (or ARNICA = Activating Regulated Necrosis In CAncer) investigates therapeutic strategies aimed at making the cancer cells more visible for the immune system, and seeks to identify biomarkers as well as treatment strategies that support this process.
Christian Doppler Forschungsgesellschaft
Boltzmanngasse 20/1/3 | 1090 Wien | Tel: +43 1 5042205 | Fax: +43 1 5042205-20 | office@cdg.ac.at
© 2020 Christian Doppler Forschungsgesellschaft